# FDA Approves Sun Pharmaceutical's Generic Drug Application Sun Pharmaceutical Industries Ltd. received FDA approval for its abbreviated new drug application (ANDA076327) on March 27, 2009, positioning the company to capture market share in the generic pharmaceutical segment. The approval strengthens Sun Pharma's portfolio in the U.S. market and enables the company to compete in a key therapeutic category.